Search Results 121-130 of 18587 for autoimmune hepatitis

  1. A Study of the Use of a New Drug in People with Non-Alcoholic Steatohepatitis (NASH) or Non-Alcoholic Fatty Liver Disease (NAFLD) - Mayo Clinic

    The purpose of this study is to assess a new drug to decrease liver fat in subjects with Non-Alcoholic Steatohepatitis or Non-Alcoholic Fatty Liver Disease.

  2. Primary sclerosing cholangitis - Doctors and departments - Mayo Clinic

    ... liver disease, Cirrhosis, Primary sclerosing cho...langitis, Portal hypertension, Hemochromatosis, Autoimmune hepatitis, Primary biliary cholangitis. Show ...

  3. Alcohol-Associated Liver Disease of a Digital Clinic Implementation

    Alcohol-Associated Liver Disease of a Digital Clinic Implementation · Overview · Participation eligibility · Participating Mayo Clinic locations · More information ...

  4. Alcohol-related liver disease is on the rise - Mayo Clinic News Network

    ... liver disease is on the rise, especially in young adults. ... Heavy drinking can cause hepatic steatosis, or increased fat in the liver, and alcoholic hepatitis, ...

  5. A Study to Evaluate Pulmonary Vascular Complications of Liver Disease 3 (PVCLD3) - Mayo Clinic

    ... liver disease. Participation eligibility. Participant eligibility includes age, gender, type and stage of disease, and previous treatments or health concerns ...

  6. Peginterferon alfa-2a (subcutaneous route) - Mayo Clinic

    Liver disease (eg, cirrhosis, autoimmune hepatitis), severe—Should not be used in patients with these conditions. Organ transplant (eg, liver)—Use of ...

  7. Alcoholic Hepatitis Clinical Trials

    The purpose of this study is to determine if extracellular (EV) counts and content can differentiate Alcoholic Hepatitis (AH) from alcoholic liver disease as ...

  8. Alex Cortez, M.D. - Doctors and Medical Staff - Mayo Clinic

    Alcoholic liver disease; Autoimmune hepatitis; Budd-Chiari syndrome; Cholangiocarcinoma; Chronic liver disease; Cirrhosis · End-stage renal disease ...

  9. A Study to Establish an Alcoholic Hepatitis Network - Mayo Clinic

    Participation eligibility · A clinical diagnosis of alcoholic hepatitis. · Liver disease significantly caused by hemochromatosis, autoimmune liver disease, Wilson ...

  10. A Biorepository of Induced Pluripotent Stem Cells from Subjects with Liver Disease - Mayo Clinic

    The stem cells will later be converted to liver cells and used to better understand liver disease and help develop treatments. Participation eligibility.